Table 3 Expression of B and T cell markers in spleen and lymph nodes.

From: Atherosclerotic plaque vulnerability is increased in mouse model of lupus

Marker (mRNA fold increase)

apoe−/− (n = 10)

apoe−/−.Yaa (n = 8)

p-value

Spleen

Th1

tim3

1.13 (1.01–1.65)

2.51 (1.71–3.47)

0.010

ifnγ

1.99 (0.55–2.27)

0.43 (0.32–1.29)

0.135

Treg

foxp3

1.21 (0.97–1.40)

0.87 (0.55–2.41)

0.756

il10

1.62 (0.41–1.96)

0.08 (0.02–0.95)

0.032

Th17

rorc

0.97 (0.58–1.34)

1.36 (0.61–2.63)

0.494

il17

0.47 (0.30–1.19)

3.84 (1.18–10.91)

0.072

Lymph nodes

cd20

0.95 (0.92–1.07)

1.19 (1.01–1.61)

0.100

cd4

0.95 (0.81–1.20)

1.46 (1.19–1.61)

0.034

Th1

tim3

1.01 (0.87–1.09)

0.87 (0.59–1.32)

0.689

ifnγ

1.23 (0.71–1.42)

0.93 (0.61–1.91)

0.961

Th2

gata3

0.93 (0.80–1.40)

1.05 (0.87–1.46)

0.625

il4

0.99 (0.76–1.21)

0.52 (0.44–0.89)

0.069

Treg

foxp3

0.98 (0.71–1.23)

1.10 (0.97–1.25)

0.317

il10

1.06 (0.72–1.40)

0.54 (0.45–0.73)

0.083

Th17

rorc

1.22 (0.73–1.42)

2.38 (1.40–2.96)

0.056

il17

1.12 (0.41–2.39)

0.69 (0.24–0.82)

0.130

  1. Data are expressed as median (interquartile range). Mann–Whitney U test was used for statistical analysis.
  2. Bold values correspond to significant p values.